Observational Retrospective study on clinical outcomes of patients receiving benralizumab in Spain.

Trial Identifier: D3250R00079
Sponsor: AstraZeneca
NCTID:: NCT04648839
Start Date: February 2021
Primary Completion Date: July 2021
Study Completion Date: July 2021

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Spain Madrid, Spain, 28041